BZ371A Phase II Trial Shows Outstanding Results in Post-Prostatectomy ED
Another Day Pharma announces successful Phase II clinical trial results for BZ371A. Study of 74 men shows combination therapy achieved 38% success rate vs 4% with standard care alone—a 10× improvement.
"We are delighted that these trial results show that BZ371A is proving to be a well-tolerated, effective option" - Paulo Lacativa
Read Full Article →